Kjensli A, Falch J A, Ryg M, Blenk T, Armbrecht G, Diep L M, Ellingsen I
Glittreklinikken, Hakadal, Norway.
Eur Respir J. 2009 May;33(5):1018-24. doi: 10.1183/09031936.00073908. Epub 2009 Jan 7.
Bone mineral density decreases with advancing chronic obstructive pulmonary disease (COPD) severity, but it is not known whether this is reflected in higher fracture rates. The present authors wanted to compare the prevalence of vertebral deformities in COPD patients with those in a population-based reference group to determine whether the number of deformities was related to the severity of COPD and how far the use of oral corticosteroids (OCS) influenced the prevalence of deformities. In the present cross-sectional study of 465 COPD patients and 462 controls, vertebral deformities were found in 31% of the COPD patients and 18% of the controls. In subjects who had never or sporadically used OCS, deformities were found in 29% of the COPD patients and 17% of the controls. In females, the average number of vertebral deformities was almost two-fold when COPD severity increased from Global Initiative of Chronic Obstructive Lung Disease stage II to III. In males, the use of OCS had a small but significant influence. Prevalence of vertebral deformities was significantly higher in chronic obstructive pulmonary disease patients than in the controls. In females, the average number of deformities was related to chronic obstructive pulmonary disease severity even after adjustment for other known risk factors. The difference between patients and controls remained significant even in those who never or sporadically used oral corticosteroids.
骨密度随慢性阻塞性肺疾病(COPD)严重程度的增加而降低,但尚不清楚这是否反映在较高的骨折发生率上。本研究作者希望比较COPD患者与基于人群的参照组中椎体畸形的患病率,以确定畸形数量是否与COPD严重程度相关,以及口服糖皮质激素(OCS)的使用对畸形患病率的影响程度。在这项对465例COPD患者和462例对照的横断面研究中,31%的COPD患者和18%的对照者存在椎体畸形。在从未或偶尔使用OCS的受试者中,29%的COPD患者和17%的对照者存在畸形。在女性中,当COPD严重程度从全球慢性阻塞性肺疾病倡议组织(Global Initiative of Chronic Obstructive Lung Disease)II期增加到III期时,椎体畸形的平均数量几乎增加了一倍。在男性中,OCS的使用有微小但显著的影响。COPD患者的椎体畸形患病率显著高于对照者。在女性中,即使在调整了其他已知危险因素后,畸形的平均数量仍与COPD严重程度相关。即使在从未或偶尔使用口服糖皮质激素的患者中,患者与对照者之间的差异仍然显著。